Literature DB >> 4218108

Effect of silybin on the hepatic microsomal drug-metabolising enzyme system in the rat.

W H Down, L F Chasseaud, R K Grundy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4218108

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  4 in total

1.  Alterations of mast cells and TGF-beta1 on the silymarin treatment for CCl(4)-induced hepatic fibrosis.

Authors:  Da-Hee Jeong; Gi-Ppeum Lee; Won-Il Jeong; Sun-Hee Do; Hai-Jie Yang; Dong-Wei Yuan; Ho-Yong Park; Kyu-Jong Kim; Kyu-Shik Jeong
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

2.  Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis.

Authors:  Naglaa M El-Lakkany; Olfat A Hammam; Walaa H El-Maadawy; Afkar A Badawy; Afaf A Ain-Shoka; Fatma A Ebeid
Journal:  Parasit Vectors       Date:  2012-01-11       Impact factor: 3.876

3.  The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half-Life.

Authors:  Yu-Hang Zhang; Chen Chu; Shaopeng Wang; Lei Chen; Jing Lu; XiangYin Kong; Tao Huang; HaiPeng Li; Yu-Dong Cai
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

4.  Epigallocatechin gallate ameliorates tetrahydrochloride-induced liver toxicity in rats via inhibition of TGFβ / p-ERK/p-Smad1/2 signaling, antioxidant, anti-inflammatory activity.

Authors:  Gomaa Mostafa-Hedeab; Manal Ewaiss Hassan; Taher F Halawa; Farooq Ahmed Wani
Journal:  Saudi Pharm J       Date:  2022-06-27       Impact factor: 4.562

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.